| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/12/2008 | US20080139578 e.g. 1-(3,3-diphenylpropanoyl)piperazine; analgesic: arthritis, headache, migraine, trigeminal neuralgia, allodynia, itch, neuropathic pain, neuralgia, diabetic neuropathy, fibromyalgia, sciatica, back pain; anticonvulsant: epilepsy; Complete Freund's Adjuvant and Capsaicin-Induced Allodynia Models |
| 06/12/2008 | US20080139577 Nitroheteroaryl-containing rifamycin derivatives |
| 06/12/2008 | US20080139576 5-Substituted 1,1-Dioxo- 1,2,5- Thiadiazolidin-3-One Derivatives |
| 06/12/2008 | US20080139575 Certain chemical entities, compositions, and methods |
| 06/12/2008 | US20080139574 Novel quinoline derivatives |
| 06/12/2008 | US20080139573 Administering thioxanthene derivative such as zuclopenthixol, zuclopenthioxol acetate or decanoate, thiotixene, chlorothixene or flupenthixol or salts thereof; depression or bipolar disorder condition resistant to antipsychotic drugs |
| 06/12/2008 | US20080139572 Diketo-piperazine and piperidine derivatives as antiviral agents |
| 06/12/2008 | US20080139571 Imidazopyrazines as protein kinase inhibitors |
| 06/12/2008 | US20080139570 e.g. N-[2-(6-{[(3,4-dichlorophenyl)methyl]amino}-2-(4-methoxyphenyl)-3-oxo-4-hydropyridino[2,3-b]pyrazin-4-yl)ethyl]acetamide; antidiabetic agent; abnormal lipid levels, cardiovascular disease, obesity, oily skin conditions, metabolic syndrome |
| 06/12/2008 | US20080139569 Novel crystalline form |
| 06/12/2008 | US20080139568 and nitric oxide synthase inhibitor; e.g. 1-(phenylmethyl)-4-piperidyl-6-phthalazine-3one; antiinflammatory agent; preserve the cellular energy level: survival of ischaemic tissues after insult; neurodegenerative diseases: stroke, Alzheimer's and Parkinson's diseases, atherosclerosis, osteoarthritis |
| 06/12/2008 | US20080139567 Psychological disorders; central nervous system disorders; antidepressants; anxiolytic agents; stress reliever; irritable bowel syndrome |
| 06/12/2008 | US20080139566 4-Benzyloxymethyl-2-hydroxymethyl-2-(tetrazol-2-yl)oxetane; DNA and RNA nucleoside polymerase inhibitor; viral, fungal, bacterial, protozoa infections; anticarcinogenic agent: breast cancer |
| 06/12/2008 | US20080139565 Anthranilic Acid Derivatives and Their Use in Treatment of Diseases of Lipid Metabolism, in Particular Dyslipidaemia |
| 06/12/2008 | US20080139564 Substituted phenyl propyl amines as histamine h3 receptor and serotonin transporter modulators |
| 06/12/2008 | US20080139563 Oxazolidinone derivatives and methods of use |
| 06/12/2008 | US20080139562 e.g. {-[3-Cyclopentyl-2-(4-methane sulfonyl-phenyl)-propionylamino]-5-methyl-thiazol-4-yl}-acetic acid ethyl ester; antidiabetic and hypoglycemic agent; non-insulin dependent diabetis, obesity, impaired glucose tolerance, eating disorder, dyslipidemia, hyperlipidemia, hypertension |
| 06/12/2008 | US20080139561 e.g. 6-(5-Cyclopropyl-1H-pyrazol-3-ylamino)-5-fluoro-2-(1-(4-fluorophenyl)ethylamino) nicotinonitrile; tropomyosin-related kinases (Trk's) inhibitor; anticarcinogenic agent; hormone related cancer, leukemia; antiinflammatory agent; arthritis, restenosis; autoimmune diseases |
| 06/12/2008 | US20080139560 Ion Channel Modulators |
| 06/12/2008 | US20080139559 Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors |
| 06/12/2008 | US20080139558 Quinolones useful as inducible nitric oxide synthase inhibitors |
| 06/12/2008 | US20080139557 [5-(Pyridin-2-ylamino)-6-oxo-1,6-dihydro-pyridin-3-yl]-(3-amido)-benzene derivatives; anticarcinogenic, antiproliferative, antiallergen, and antiinflammatory agents; lymphoma, leukemia, autoimmune diseases; Bruton's tyrosine kinase inhibitors |
| 06/12/2008 | US20080139556 1-(3-Trifluoromethyl-benzenesulfonyl)-piperidine-2-carboxylic acid [(S)-1-(4-dimethylamino-phenylcarbamoyl)-2-(4-methoxy-phenyl)-ethyl]-amide;FK-binding protein/immunophilins modulator; neurodegenerative diseases; Parkinson's disease, multiple sclerosis, Alzheimer's disease, stroke, spinal cord injury |
| 06/12/2008 | US20080139555 1-[(4-{[4-(3-amino-6-methylphenyl)piperidyl]methyl}phenyl)sulfonyl]-4; melatonin-concentrating hormone (MCH1) receptor ligand; antidepressant, anxiolytic, antidiabetic agent |
| 06/12/2008 | US20080139554 Spiro-piperidine derivatives |
| 06/12/2008 | US20080139553 Spiro-piperidine derivatives |
| 06/12/2008 | US20080139552 Indoles |
| 06/12/2008 | US20080139551 4-(4-methyl-piperazin-1-yl)-2-oxo-1-phenyl-1,2-dihydro-quinoline-3-carboxylic acid ethyl ester; anticarcinogenic, antiinflammatory agent; septic shock, respiratory distress syndrome, rheumatoid arthritis, osteoarthritis, asthma, autoimmune disorder, diabetes, multiple sclerosis, Cushing's disease |
| 06/12/2008 | US20080139550 e.g. {5-Chloro-2-[4-(2-oxo-2,3-dihydro-benzooxazol-7-yl)-piperidine-1-carbonyl]-1H-indol-7-yl}-acetonitrile; vasopressin receptors antagonist; antidepressant, anxiolytic agent; dysmenorrhea, hypertension, inappropriate secretion of vasopressin, liver cirrhosis, obsessive compulsive disorder |
| 06/12/2008 | US20080139549 Indoles |
| 06/12/2008 | US20080139548 Indoles |
| 06/12/2008 | US20080139547 N-Hydroxyalkynylbenzamide (or hydroxamate) derivatives; anticarcinogenic and antiproliferative agents |
| 06/12/2008 | US20080139546 e.g. 3-(3,4-dihydroquinolin-1(2H)-yl)-N-{[8-methyl-2,3-dihydro[1,4]dioxino[2,3-f]quinolin-2-yl]methyl}propan-1-amine; modulators of serotonin 5-HT1A receptor activity and/or serotonin reuptake; antidepressant, anxiolytic agent, cognition activator; schizophrenia, sexual disorders |
| 06/12/2008 | US20080139545 Non-aminoglycoside antibiotic such as a quinolone antibiotic, ciprofloxacin or ofloxacin; antiinflammatory agent such as dexamethasone; and a biofilm-dissolving agent; otitis; cleaning contact lenses or surgical and dental equipment |
| 06/12/2008 | US20080139544 Modulators of CCR5(chemokine) receptors; lymphadenopathy associated and human T-cell leukemia/lymphoma viruses; AIDS infections; autoimmune diseases; antiinflammatory agents; derivatives of 1-oxa-3,8-diaza-spiro[4.5]decan-2-one and 1-oxa-3,9-diaza-spiro[5.5]undecan-2-one |
| 06/12/2008 | US20080139541 amyloid precursor protein and gamma -secretase inhibitor; 3,4,6,7,8,9-Hexahydro-2-methyl-3-oxo-2H-naphtho[2,3-e]-1,2-thiazine-4-(4-chloro)carboxanilide 1,1-dioxide; neurodegenerative disease: Alzheimer's disease, amyloid plaque, Parkinson's disease, Down's syndrome, hemorrhage, arteriosclerosis |
| 06/12/2008 | US20080139540 Antibacterial Agents |
| 06/12/2008 | US20080139539 6-{[(2-{4-[3-fluoro-6-(methyloxy)-1,5-naphthyridin-4-yl]-1-piperazinyl}ethyl)amino]methyl}-2H-pyrido[3,2-b][1,4]thiazin-3-one; bacterial infections; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli |
| 06/12/2008 | US20080139538 Tertiary Carbinamines Having Substituted Heterocycles Which Are Active As Beta-Secretase Inhibitors For The Treatment Of Alzheimer's Disease |
| 06/12/2008 | US20080139537 (phenyl(1,3)diazepyl-2-one-piperidyl)-[1(benzyl)-1(piperidyl)-methyl] ester derivatives; calcitonin gene related peptide inhibitor; disregulation the brain-gut axis, as a result of sensitization of visceral afferent mechanisms, most likely peptidergic C-fibers containing CGRP; gastrointrestinal disorder |
| 06/12/2008 | US20080139536 Benzodiazepines for Treating or Preventing Rsv Infection |
| 06/12/2008 | US20080139535 1-(2-naphthylsulfonyl)-4-(5-hydroxyaminocarbonylthiazol-2-yl)piperazine; antiproliferative agent; cell cycle arrest, cellular differentiation, apoptosis and reversal of the transformed phenotype; |
| 06/12/2008 | US20080139534 Bisbenzamidines and bisbenzamidoximes for the treatment of human African trypanosomiasis |
| 06/12/2008 | US20080139533 Substituted 4-imidazoles |
| 06/12/2008 | US20080139532 Tetrahydrobenzazepine Derivatives as Modulators of Dopamine D3 Receptors (Antipsychotic Agents) |
| 06/12/2008 | US20080139531 Use of connective tissue mast cell stabilizers to facilitate ocular surface re-epithelization and wound repair |
| 06/12/2008 | US20080139530 7-Aryl 1,5-Dihydro-4,1-Benzoxazepin-2(3H)-One Derivatives And Their Use As Progesterone Receptor Modulators |
| 06/12/2008 | US20080139529 Nervous system, neurodegenerative, psychiatric, sexual, attention deficit, and psychological disorders; cognition activators, antidepressants, anxiolytic agents; alcoholism, drug abuse, traumas, strokes, epilepsy, schizophrenia, autism, and/or Alzheimer's disease treatment |
| 06/12/2008 | US20080139528 Cefdinir oral suspension |
| 06/12/2008 | US20080139527 Methods for treatment of heart disease |
| 06/12/2008 | US20080139526 Modified release dosage forms of amoxicillin |
| 06/12/2008 | US20080139525 Antioxidant therapies |
| 06/12/2008 | US20080139524 Pharmaceutical formulation comprising a metaloporphyrin and method for its purification and use |
| 06/12/2008 | US20080139523 Oxime-containing macrocyclic acyl guanidines as beta-secretase inhibitors |
| 06/12/2008 | US20080139522 Dexamethasone disodium phosphate;xanthan gum; sodium (di)hydrogen phosphate buffer; sodium citrate; and water; ophthalmology; vision defects; corneal epithelial cells; wound healing agents |
| 06/12/2008 | US20080139521 Use of Megestrol Acetate for Improving Heart Function and the Treatment of Heart Insufficiency |
| 06/12/2008 | US20080139520 Up or down regulation of fat and/or cholesterol uptake from the intestine by administering to a mammal in need thereof an effective amount of a regulator of pancreatic IB PLA2 functionality |
| 06/12/2008 | US20080139519 Applying moist heat to a suspension of a labile glucocorticosteroid, in particular, budesonide or beclomethasone dipropionate, for a sterilizing-effective time; for preventing, reversing, and/or reducing symptoms of allergic and/or inflammatory conditions |
| 06/12/2008 | US20080139518 Topical compositions for treatment of skin conditions |
| 06/12/2008 | US20080139517 Administering therapeutically effective amount of at least one agent capable of inhibiting a neuronal cell cycle progression for therapy of age associated memory impairment, mild cognitive impairment (MCI), Alzheimer's disease, alone or in combination with agent capable of reducing mitogenic stimulation |
| 06/12/2008 | US20080139516 4-diethoxyphosphinoylmethyl-N-(4-bromo-2-cyanophenyl)benzamide; antitumor agent; colon cancer; |
| 06/12/2008 | US20080139515 Stable amifostine liquid concentrate |
| 06/12/2008 | US20080139514 Diphosphonic acid pharmaceutical compositions |
| 06/12/2008 | US20080139513 Active agent has one or more of following properties: melting point greater than150 degrees C., molecular weight greater than 500 Da, Log P is 1-3, high therapeutically effective dose; raloxifene is present in particle form in emulsion with solvent, non-miscible liquid, stabilizer, water; osteoporosis |
| 06/12/2008 | US20080139512 Such as mustard gas and other chemical warfare agents; contacting tissue with matrix metalloproteinase inhibitor, Ilomastat, for example, and also some type of anti-inflammatory agent |
| 06/12/2008 | US20080139511 Combination Therapies Employing Ace Inhibitors and Uses Thereof for the Treatment of Diabetic Disorders |
| 06/12/2008 | US20080139510 Treatment of migraine headaches with sublingual amino acids |
| 06/12/2008 | US20080139509 Pancratistatin cyclic phosphate prodrugs and phenpanstatin cyclic phosphate prodrugs |
| 06/12/2008 | US20080139508 Ibandronate sodium propylene glycol solvate and processes for the preparation thereof |
| 06/12/2008 | US20080139507 Method of Treating Skin Condition Including Acne, Skin Aging, Body Odor & Diaper Rash by Zinc Zeolite Clathrates |
| 06/12/2008 | US20080139505 Potentiators Of Glutamate Receptors |
| 06/12/2008 | US20080139504 Method for Improving the Fertility of Animals |
| 06/12/2008 | US20080139503 Inhibiting FGF growth factor with heparins; antitumor agents; angiogenesis inhibitor; antidiabetic agent treating diabetic retinopathy; antiinflammatory agent; treating retrolenticular fibroplasia, psoriasis, restenosis after angioplasty and after coronary by-pass; drug delivery |
| 06/12/2008 | US20080139502 Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 06/12/2008 | US20080139501 Uses of product in field of biodegradable plastic materials for preparation of sanitary and surgical articles, in pharmaceutical and cosmetic fields; degradation by-products, such as lactic acid or glycolic acid, are metabolized by body and eliminated, making grafted product completely bioresorbable |
| 06/12/2008 | US20080139500 Use of composite monomer or monomers, catalyst, sodium hyaluronate or hyaluronic acid, glucosamide sulfate, chondroiten sulfate or chlorides, for the treatment of osteoarthritis by intraarticular application to a hip or knee joint |
| 06/12/2008 | US20080139499 Producing a neutral lipid-depleted beta-serum dairy product by subjecting dried beta-serum to a near critical carbon dioxide extraction process using near critical carbon dioxide or dimethyl ether; use as ingredients in infant formulas, sports nutrition and food for the elderly |
| 06/12/2008 | US20080139498 Agents Containing Folic Acid, Vitamin B6 and Vitamin B12, and the Use Thereof |
| 06/12/2008 | US20080139497 Use of ATP in controlled regional reperfusion as treatment during acute myocardial infarction |
| 06/12/2008 | US20080139496 Minimising dosage required of chemotherapeutic agents for their use in antiviral, antibacterial, antiparasitic and anticancer chemotherapy; for treating neoplasms and tumours, viral, bacterial, or parasite infections |
| 06/12/2008 | US20080139495 Synergistic mixture of dipyrido[2,3-b; 3,2f][1-4]diaxepines and 3'-deoxy-3'-fluorothymidine, -cytosine, -adenosine, or guanosine type derivatives; human retrovirus (HRV), hepatitis B virus (HBV), human T-cell leukemia/lymphoma virus, AIDS |
| 06/12/2008 | US20080139494 Introducing genetic material topically or by lavage into mucosal tissue cells of an individual, including rectal, vaginal, urethral, sublingual and buccal; used to deliver genetic material that encodes protein targets for immunization against pathogen infection, hyperproliferative or autoimmune diseases |
| 06/12/2008 | US20080139493 delivery of various cargo moieties into cells; more amenable than peptide "protein transduction domains" due to their ease of preparation and in vivo stability by virtue of their resistance to cellular enzymes that degrade peptides |
| 06/12/2008 | US20080139491 Method For Investigating Cytosine Methylation in Dna Sequences By Means of Triplex-Forming Oligomers |
| 06/12/2008 | US20080139490 Rate of dissolution; ease of handling; storage stability; release profile; powder X-ray diffraction pattern peaks at 6.4, 9.9 and 13.2 degrees 2 theta +-0.2 degrees 2 theta; infrared spectrum peaks at 3544, 1732, and 1009 cm-1 |
| 06/12/2008 | US20080139489 Use of ketolides for preventing arterial thrombotic complications related to atherosclerosis |
| 06/12/2008 | US20080139488 Curative; high tolerance, nonirritating; amenable to long term regimen |
| 06/12/2008 | US20080139486 Red wine distillates |
| 06/12/2008 | US20080139485 Comprised of at least residues of sialic acid, galactose with anionic moiety at position 6, n-acetylglucosamine and fucose; asthma, allergic reactions |
| 06/12/2008 | US20080139484 Sodium dependent glucose transporter inhibitory activity; normalizing blood sugar levels; diabetes, postprandial hyperglycemia, impaired glucose tolerance, diabetic complications, obesity |
| 06/12/2008 | US20080139483 Drug combination for hypertensive disorders |
| 06/12/2008 | US20080139482 Intermediate duration neuromuscular blocking agents and antagonists thereof |
| 06/12/2008 | US20080139481 High binding activity modified peptides; blood stability, receptor selectivity, barrier crossing; N-terminus moieties |
| 06/12/2008 | US20080139480 Imatinib resistant leukemia; synergistic treatment with such as ciclopirox |
| 06/12/2008 | US20080139476 Caspase-8 interacting proteins |
| 06/12/2008 | US20080139475 Inhibition of atf2 activity to treat cancer |
| 06/12/2008 | US20080139472 Preventing and/or restoring cognitive dysfunction in fragile X syndrome; AMPA potentiation |
| 06/12/2008 | US20080139469 Containing fibroblast growth factor or partial peptide active ingredient; promoting follicle growth |
| 06/12/2008 | US20080139467 Method and Products For the Selective Degradation of Proteins |
| 06/12/2008 | US20080139461 Containing the sequence RGD for the preparation of appropriately functionalised antagonists of alpha v beta 3 and alpha v beta 5 integrins; treatment of altered angiogenic phenomena or for the preparation of diagnostically useful compounds |